Brayne C, Wu Y
Am J Alzheimers Dis Other Demen. 2022; 37:15333175221104347.
PMID: 36000966
PMC: 10581148.
DOI: 10.1177/15333175221104347.
Carcaillon-Bentata L, Quintin C, Boussac-Zarebska M, Elbaz A
PLoS Med. 2021; 18(9):e1003801.
PMID: 34555025
PMC: 8496799.
DOI: 10.1371/journal.pmed.1003801.
Robbins M, Clayton E, Kaminski Schierle G
Acta Neuropathol Commun. 2021; 9(1):149.
PMID: 34503576
PMC: 8428049.
DOI: 10.1186/s40478-021-01246-y.
Won S, Park Y, Park M, Ahn S, Kim J, Lee S
Korean J Radiol. 2020; 21(12):1345-1354.
PMID: 33169553
PMC: 7689149.
DOI: 10.3348/kjr.2020.0715.
Yue A, Han X, Mao E, Wu G, Gao J, Huang L
Medicine (Baltimore). 2020; 99(33):e21242.
PMID: 32871984
PMC: 7437843.
DOI: 10.1097/MD.0000000000021242.
Impact of Baseline Features and Risk Factor Control on Cognitive Function in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial.
Turan T, Al Kasab S, Smock A, Cotsonis G, Bachman D, Lynn M
Cerebrovasc Dis. 2019; 47(1-2):24-31.
PMID: 30763948
PMC: 9936320.
DOI: 10.1159/000497245.
Barriers in providing primary care for immigrant patients with dementia: GPs' perspectives.
Vissenberg R, Uysal O, Goudsmit M, van Campen J, Buurman-van Es B
BJGP Open. 2019; 2(4):bjgpopen18X101610.
PMID: 30723796
PMC: 6348325.
DOI: 10.3399/bjgpopen18X101610.
A review of the 10/66 dementia research group.
Prina A, Mayston R, Wu Y, Prince M
Soc Psychiatry Psychiatr Epidemiol. 2018; 54(1):1-10.
PMID: 30467589
PMC: 6336743.
DOI: 10.1007/s00127-018-1626-7.
A Systematic Review and Meta-Analysis on the Prevalence of Dementia in Europe: Estimates from the Highest-Quality Studies Adopting the DSM IV Diagnostic Criteria.
Bacigalupo I, Mayer F, Lacorte E, Di Pucchio A, Marzolini F, Canevelli M
J Alzheimers Dis. 2018; 66(4):1471-1481.
PMID: 30412486
PMC: 6294583.
DOI: 10.3233/JAD-180416.
Effect of monosodium L-glutamate (umami substance) on cognitive function in people with dementia.
Kouzuki M, Taniguchi M, Suzuki T, Nagano M, Nakamura S, Katsumata Y
Eur J Clin Nutr. 2018; 73(2):266-275.
PMID: 30349139
PMC: 6365374.
DOI: 10.1038/s41430-018-0349-x.
Evolution of dementia diagnosis over time (1988-2013): Evidence from French and English cohorts. Implication for secular trends analyses.
Grasset L, Matthews F, Peres K, Foubert-Samier A, Helmer C, Dartigues J
Alzheimers Dement (Amst). 2018; 10:490-497.
PMID: 30310851
PMC: 6178133.
DOI: 10.1016/j.dadm.2018.07.005.
The prevalence of dementia in a Portuguese community sample: a 10/66 Dementia Research Group study.
Goncalves-Pereira M, Cardoso A, Verdelho A, da Silva J, Caldas de Almeida M, Fernandes A
BMC Geriatr. 2017; 17(1):261.
PMID: 29115922
PMC: 5688818.
DOI: 10.1186/s12877-017-0647-5.
Synergistic effects of cognitive impairment on physical disability in all-cause mortality among men aged 80 years and over: Results from longitudinal older veterans study.
Yu W, Chou M, Peng L, Lin Y, Liang C, Chen L
PLoS One. 2017; 12(7):e0181741.
PMID: 28746360
PMC: 5528830.
DOI: 10.1371/journal.pone.0181741.
The changing prevalence and incidence of dementia over time - current evidence.
Wu Y, Beiser A, Breteler M, Fratiglioni L, Helmer C, Hendrie H
Nat Rev Neurol. 2017; 13(6):327-339.
PMID: 28497805
DOI: 10.1038/nrneurol.2017.63.
Estimating the prevalence of dementia using multiple linked administrative health records and capture-recapture methodology.
Waller M, Mishra G, Dobson A
Emerg Themes Epidemiol. 2017; 14:3.
PMID: 28261312
PMC: 5327574.
DOI: 10.1186/s12982-017-0057-3.
The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care.
Wimo A, Jonsson L, Fratiglioni L, Sandman P, Gustavsson A, Skoldunger A
Alzheimers Res Ther. 2016; 8(1):59.
PMID: 27986093
PMC: 5162098.
DOI: 10.1186/s13195-016-0215-9.
Cross Sectional Associations between Socio-Demographic Factors and Cognitive Performance in an Older British Population: The European Investigation of Cancer in Norfolk (EPIC-Norfolk) Study.
Hayat S, Luben R, Dalzell N, Moore S, Anuj S, Matthews F
PLoS One. 2016; 11(12):e0166779.
PMID: 27930656
PMC: 5145160.
DOI: 10.1371/journal.pone.0166779.
A systematic review of the quality of studies on dementia prevalence in Italy.
Bruti G, Cavallucci E, Mancini M, Bitossi A, Baldereschi M, Sorbi S
BMC Health Serv Res. 2016; 16(1):615.
PMID: 27784338
PMC: 5081842.
DOI: 10.1186/s12913-016-1871-y.
A systematic review of the quality of studies on dementia prevalence in Italy.
Bruti G, Cavallucci E, Mancini M, Bitossi A, Baldereschi M, Sorbi S
BMC Health Serv Res. 2016; 16(1):507.
PMID: 27659233
PMC: 5034570.
DOI: 10.1186/s12913-016-1741-7.
Velnacrine in Alzheimer's Disease : An Initial Appraisal of its Clinical Potential.
Goa K, Fitton A
CNS Drugs. 2016; 1(3):232-40.
PMID: 27520522
DOI: 10.2165/00023210-199401030-00008.